Camurus AB

CAMX.ST · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

342 SEK (≈ 35.56 USD)

Margin of Safety

-86.7 %

Rating

BEOBACHTEN

Camurus AB develops and markets specialty pharmaceutical products based on proprietary depot formulation technology (FluidCrystal), which releases active ingredients in a controlled manner over weeks to months, thereby improving compliance in chronic diseases such as opioid addiction, cancer, and rare diseases.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.